Rolapitant hydrochloride hydrate
≥95%
- Product Code: 37084
CAS:
914462-92-3
| Molecular Weight: | 554.95 g./mol | Molecular Formula: | C₂₅H₂₉ClF₆N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD19443696 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, store under inert gas |
Product Description:
Rolapitant hydrochloride hydrate is primarily used as an antiemetic to prevent nausea and vomiting caused by chemotherapy, particularly in cancer patients undergoing highly emetogenic chemotherapy regimens. It works by selectively inhibiting the neurokinin-1 (NK1) receptor, which plays a key role in the body's vomiting reflex. This medication is often administered in combination with other antiemetic drugs, such as dexamethasone and a 5-HT3 receptor antagonist, to enhance its effectiveness. It is typically given orally as a single dose prior to chemotherapy, providing long-lasting protection against delayed-phase chemotherapy-induced nausea and vomiting (CINV), which can occur 24 hours or more after treatment. Its use significantly improves the quality of life for patients by reducing the debilitating side effects of chemotherapy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿6,678.00 |
+
-
|
| 0.010 | 10-20 days | ฿10,935.00 |
+
-
|
| 0.025 | 10-20 days | ฿20,556.00 |
+
-
|
| 0.050 | 10-20 days | ฿32,238.00 |
+
-
|
Rolapitant hydrochloride hydrate
Rolapitant hydrochloride hydrate is primarily used as an antiemetic to prevent nausea and vomiting caused by chemotherapy, particularly in cancer patients undergoing highly emetogenic chemotherapy regimens. It works by selectively inhibiting the neurokinin-1 (NK1) receptor, which plays a key role in the body's vomiting reflex. This medication is often administered in combination with other antiemetic drugs, such as dexamethasone and a 5-HT3 receptor antagonist, to enhance its effectiveness. It is typically given orally as a single dose prior to chemotherapy, providing long-lasting protection against delayed-phase chemotherapy-induced nausea and vomiting (CINV), which can occur 24 hours or more after treatment. Its use significantly improves the quality of life for patients by reducing the debilitating side effects of chemotherapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :